Executive Medical Director, Early Dev - Inflammation
Amgen
About this role
The Executive Medical Director, Early Development – Inflammation at Amgen leads the development of Inflammation programs, translating strategies into clinical study designs, and ensuring scientific rigor. They collaborate with cross-functional teams and regulatory agencies to advance molecules to medicines.
Skills
Qualifications
About Amgen
amgen.comAmgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Recent company news
AmgenAmgen Named to Forbes’ 2026 List of America’s Best Large Employers
2 days ago
MarketBeatFranklin Resources Inc. Lowers Position in Amgen Inc. $AMGN
4 hours ago
Yahoo FinanceAmgen Touts 2025 Double-Digit Growth, MariTide Obesity Push and BiTE Momentum at Leerink Conference
13 hours ago
24/7 Wall St.Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained
1 day ago
Finviz - Stock ScreenerQ4 Earnings Highs And Lows: Amgen (NASDAQ:AMGN) Vs The Rest Of The Therapeutics Stocks
3 days ago
About Amgen
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Amgen.
Salary
$361k – $414k
per year
More jobs at Amgen
Similar Jobs
Medical Director - Ophthalmology
Roche
Medical Director — Multiple Sclerosis
Roche
Clinical Development Medical Director- Inflammation
GSK plc
Senior Director, Biostatistics - Immunology & Inflammation
Regeneron Pharmaceuticals
Medical Director, Gastroenterology, Early Clinical Development
Roche
Executive Medical Director - Physician -Early Clinical Development, Immunology
Eli Lilly and Company